NDC 42858-610 – Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release

Dextroamphetamine Saccharate 2.5 mg/1; Amphetamine Aspartate Monohydrate 2.5 mg/1; Dextroamphetamine Sulfate 2.5 mg/1; Amphetamine Sulfate 2.5 mg/1 · Capsule, Extended Release · Oral

Human Prescription Drug DEA schedule CII

Product NDC42858-610

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release
Generic name
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE
Labeler
Rhodes Pharmaceuticals LLC
Dosage form
Capsule, Extended Release
Route
Oral
Marketing category
ANDA · ANDA210651
Marketed since
August 22, 2019
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate →

Package NDC codes (1)

Package NDCDescriptionSince
42858-610-01100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42858-610-01)Aug 22, 2019

Other Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate products